AbbVie: The Tsunami Heading Towards Investors

AbbVie (NYSE:ABBV) focuses on discovering, developing, and marketing branded therapeutics protected by intellectual property rights, allowing it to command higher prices and margins. However, once the exclusivity expires (usually after 15-20 years), other companies can produce and sell generic…#abbv #abbottlaboratories #abt #humira #onceamgen #amgn #amgevita #fda #amgen #mylan

Source: Reuters: Health - April 14, 2023 Category: Consumer Health News Source Type: news